Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · May 20, 2024

Weight Loss and CVD Risk Outcomes of Semaglutide

International Journal of Obesity (2005)

 

Additional Info

International Journal of Obesity (2005)
Weight loss and cardiovascular disease risk outcomes of semaglutide: a one-year multicentered study
Int J Obes (Lond) 2024 May 01;48(5)662-667, W Ghusn, S Fansa, D Anazco, E Tama, B Nicolalde, K Gala, A De la Rosa, D Sacoto, L Cifuentes, A Campos, F Feres, MD Hurtado, A Acosta

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading